DUSP11: A Potential Drug Target and Biomarker for Serine/Threonine Specific Protein Phosphatase

Target Name: DUSP11

NCBI ID: G8446

DUSP11

DUSP11: A Potential Drug Target and Biomarker for Serine/Threonine Specific Protein Phosphatase

Introduction

Protein phosphatases are crucial enzymes involved in various cellular signaling pathways. Among them, DUSP11 (serine/threonine specific protein phosphatase) is a protein that has received significant attention due to its unique function in the regulation of protein kinase (PK) signaling pathway. DUSP11 is an essential enzyme for the regulation of PK signaling, which is a critical pathway involved in cell signaling, development, and survival. In this article, we will discuss the discovery, function, and potential clinical applications of DUSP11 as a drug target and biomarker.

Discovery and Characterization of DUSP11

DUSP11 was first identified as a gene encoding a protein with sequence similarities to other known protein phosphatases, including casein kinase (CK) and heat shock protein (HSP) kinases. The protein encoded by DUSP11 has a unique N-terminus that is specific for serine /threonine phosphorylations. To determine the function of DUSP11, researchers expressed the protein in various cell types and used it to treat cell proliferation assays. They found that DUSP11 inhibited the activity of several PK kinases, including casein kinase, which suggested that DUSP11 may be a negative regulator of PK signaling.

Function and Mechanism of DUSP11

DUSP11 is an enzyme that catalyzes the phosphate orylation of specific target proteins, including casein kinase (CK), heat shock protein (HSP) 16.2 (HSP16.2), and heat shock protein (HSP) 18.2 (HSP18.2). The catalytic center of DUSP11 consists of a nucleotide-binding oligomerization domain (NBO), a catalytic domain, and a C-terminal region. The NBO is responsible for nucleotide binding, while the catalytic domain is responsible for the catalytic activity. The C-terminal region contains a unique protein-coding region that is specific for DUSP11's target proteins.

DUSP11's unique serine/threonine specificity is achieved through its specific phosphorylation site. The serine/threonine phosphorylations are important for the regulation of various cellular processes, including cell signaling, DNA replication, and protein stability. The specific phosphorylation site of DUSP11 is located at the N-terminus, which is the region responsible for the interaction with the target proteins.

Mutation Analysis

To determine the role of DUSP11 in various cellular processes, researchers used a variety of cell lines and screening approaches. They found that DUSP11 was involved in the regulation of cell signaling, cell division, and DNA replication. For example, DUSP11 was shown to inhibit the activity of the PK kinase, including casein kinase, which is involved in cell signaling. Additionally, DUSP11 was shown to promote the activity of the topoisomerase, which is involved in the regulation of DNA replication.

DUSP11 has also been shown to play a role in the regulation of cell division. For example, DUSP11 has been shown to inhibit the activity of the transcription factor, which is involved in the regulation of cell growth and division. Additionally, DUSP11 has been shown to promote the activity of the p53 tumor suppressor protein, which is involved in the regulation of cell growth and apoptosis.

DUSP11 has also been shown to play a role in the regulation of protein stability. For example, DUSP11 has been shown to

Protein Name: Dual Specificity Phosphatase 11

Functions: Possesses RNA 5'-triphosphatase and diphosphatase activities, but displays a poor protein-tyrosine phosphatase activity. In addition, has phosphatase activity with ATP, ADP and O-methylfluorescein phosphate (in vitro). Binds to RNA. May participate in nuclear mRNA metabolism

The "DUSP11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets